Explore the complete record of transactions filed by Rice Michael, Chairman and Chief Executive Officer. Director active across 1 companies, notably Biolife Solutions INC. In total, 53 disclosures have been logged. Total volume traded: €1.1m. The latest transaction was disclosed on 28 June 2022 — Cession. Regulator: SEC (Form 4). All data is free.
25 of 53 declarations
Michael Rice serves as Chairman and Chief Executive Officer of BioLife Solutions, Inc., a U.S.-listed company focused on bioproduction tools and services for the cell and gene therapy market. In this role, he oversees corporate strategy, commercial growth, and operational execution. Public company and investor-facing sources identify him as a central leader within BioLife Solutions’ management team, with responsibilities that include governance, strategic direction, and executive communication with shareholders. ([craft.co](https://craft.co/biolife-solutions/executives?utm_source=openai)) Rice’s professional background is rooted in the life sciences industry. Available public profiles indicate that he has more than 25 years of leadership experience across the sector, including prior executive roles at CryoLife, Affymax, and Prometheus Laboratories. That background points to a career built around scaling innovation-driven businesses, leading regulated organizations, and bringing biomedical products and platforms to market. ([csimarket.com](https://csimarket.com/stocks/BLFS-Officers-Directors.html?utm_source=openai)) At BioLife Solutions, Rice has held prominent leadership positions over time, including President, Chief Executive Officer, and Director, and more recent company references describe him as Chairman and CEO. His tenure has been associated with the company’s transformation into a multi-platform provider serving advanced therapies, with solutions used to preserve biologic materials through manufacturing, storage, and distribution. ([marketsmojo.com](https://www.marketsmojo.com/news/stocks-in-action/who-are-in-the-management-team-of-biolife-solutions-inc-3168047?utm_source=openai)) Among his notable contributions is his role in guiding BioLife’s positioning in the cell and gene therapy ecosystem, where product reliability, cold-chain integrity, and manufacturing performance are critical. Company communications also suggest a leadership style focused on operational discipline, strategic execution, and active engagement with investors. Because the public sources reviewed do not provide a fully detailed, independently verified career chronology, the most accurate description is that Rice is a seasoned life sciences executive whose expertise spans corporate leadership, governance, and commercialization in biopharma. ([biolifesolutions.com](https://www.biolifesolutions.com/company/?utm_source=openai))